We are live on ! Find out more
AI

Analytic Investors Portfolio holdings

AUM $8.93B
1-Year Est. Return 13.54%
This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+13.54%
3 Year Est. Return
+42.14%
5 Year Est. Return
10 Year Est. Return
AUM
$6.57B
AUM Growth
+$536M
Cap. Flow
+$353M
Cap. Flow %
5.37%
Top 10 Hldgs %
20.82%
Holding
665
New
181
Increased
125
Reduced
203
Closed
118

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$61.5M
2
AZO icon
AutoZone
AZO
+$57.7M
3
SYY icon
Sysco
SYY
+$44.3M
4
TGT icon
Target
TGT
+$41.7M
5
CSCO icon
Cisco
CSCO
+$35.4M

Sector Composition

Rank Sector Weight
1 Consumer Staples 19.41%
2 Healthcare 17.56%
3 Financials 11.47%
4 Technology 9.26%
5 Communication Services 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYB icon
51
LyondellBasell Industries
LYB
$18.9B
$33.7M 0.51%
+379,247
New +$31.9M
QCOM icon
52
Qualcomm
QCOM
$179B
$33M 0.5%
+417,876
New +$31.5M
FDS icon
53
Factset
FDS
$9.45B
$32.4M 0.49%
300,632
+116,562
+63% +$12.3M
KR icon
54
Kroger
KR
$35.5B
$31.6M 0.48%
1,448,128
-325,782
-18% -$6.48M
MSFT icon
55
Microsoft
MSFT
$2.89T
$31.3M 0.48%
763,470
+359,516
+89% +$13.5M
PSX icon
56
Phillips 66
PSX
$83.3B
$30.5M 0.46%
395,947
-5,909
-1% -$450K
DD icon
57
DuPont de Nemours
DD
$18.9B
$30.4M 0.46%
247,258
+45,662
+23% +$5.38M
JLL icon
58
Jones Lang LaSalle
JLL
$15.5B
$29.9M 0.46%
252,387
+67,588
+37% +$7.78M
XOM icon
59
ExxonMobil
XOM
$642B
$29.8M 0.45%
304,764
-249,907
-45% -$23.8M
CVS icon
60
CVS Health
CVS
$137B
$28.3M 0.43%
377,860
+6,580
+2% +$465K
MNST icon
61
Monster Beverage
MNST
$93.2B
$28.2M 0.43%
3,349,644
-93,000
-3% -$1.09M
AZO icon
62
AutoZone
AZO
$50.2B
$28.1M 0.43%
52,383
-111,179
-68% -$57.7M
FRX
63
DELISTED
FOREST LABORATORIES INC
FRX
$28.1M 0.43%
304,403
+296,271
+3,643% +$23.9M
JCI icon
64
Johnson Controls International
JCI
$87.4B
$27.5M 0.42%
+555,534
New +$28.1M
AWH
65
DELISTED
Allied World Assurance Co Hld Lt
AWH
$27.1M 0.41%
+788,493
New +$27.1M
PETM
66
DELISTED
PETSMART INC
PETM
$26.8M 0.41%
389,284
-31,849
-8% -$2.11M
BPOP icon
67
Popular Inc
BPOP
$10.9B
$26.5M 0.4%
854,215
-56,164
-6% -$1.6M
CBRE icon
68
CBRE Group
CBRE
$42.1B
$26.4M 0.4%
963,737
+129,480
+16% +$3.49M
SO icon
69
Southern Company
SO
$109B
$25.9M 0.39%
588,725
-678,152
-54% -$28.4M
IDXX icon
70
Idexx Laboratories
IDXX
$43.9B
$25.3M 0.38%
416,754
+319,734
+330% +$19M
AXP icon
71
American Express
AXP
$229B
$25.2M 0.38%
279,417
+269,707
+2,778% +$24.1M
M icon
72
Macy's
M
$6.57B
$24.9M 0.38%
420,462
+372,105
+769% +$20.7M
COF icon
73
Capital One
COF
$127B
$24.8M 0.38%
+322,026
New +$23.6M
BAX icon
74
Baxter International
BAX
$12.1B
$24.8M 0.38%
621,284
+1,793
+0.3% +$67K
LEA icon
75
Lear
LEA
$7.26B
$23.2M 0.35%
276,894
-176,549
-39% -$14.1M

Similar funds

Analytic Investors's Q1 2014 Portfolio in Review

As of Q1 2014, Analytic Investors held 665 positions worth $6.57B, up 8.9% from $6.04B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Analytic Investors deployed $353M of net new capital in Q1 2014, opening 181 new positions and adding to 125 existing holdings. Its largest new stake was PARTNERRE LTD: 727,121 shares worth $75.3M.

By sector, the portfolio is most concentrated in Consumer Staples at 19% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Intuitive Surgical, an estimated $61.5M trimmed.

  • Analytic Investors's largest Q1 2014 buy was PARTNERRE LTD: 727,121 shares worth $75.3M.
  • Analytic Investors added most to Merck in Q1 2014, an estimated $103M increase.
  • Analytic Investors's biggest Q1 2014 reduction was Intuitive Surgical, cutting an estimated $61.5M.
  • Analytic Investors fully exited Oracle in Q1 2014, selling an estimated $29.2M.
  • Analytic Investors's ten largest holdings make up 21% of its $6.57B portfolio in Q1 2014.
  • Analytic Investors opened 181 new positions and closed 118 in Q1 2014.
  • Analytic Investors's portfolio value rose 8.9% quarter-over-quarter to $6.57B.

Based on Analytic Investors's 13F filing for Q1 2014, filed 12 May 2014.